India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases
MedGenome reaffirms its commitment to broaden access to quality and affordable genetic solutions for all
Co–Founder Sam Santhosh steps down as Chairman and Group CEO; will remain on Board of Directors. Co–founder Mahesh Pratapneni appointed Group CEO. Dr. Felix Olale appointed Chairman of the Board
The drug will target specific genetic mutations prevalent in certain types of cancers
Subscribe To Our Newsletter & Stay Updated
